XRAY - Dentsply Sirona Inc.
NASDAQ
->
Healthcare
->
Medical Instruments & Supplies
Charlotte,
United States
Type: Equity
XRAY price evolution
XRAY
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $279 | $291 | $334 | |
| Short term investments | ||||
| Net receivables | $671 | $591 | $656 | $695 |
| Inventory | $619 | $608 | $613 | $624 |
| Total current assets | $1921 | $1758 | $1902 | $1973 |
| Long term investments | ||||
| Property, plant & equipment | $967 | $951 | $953 | $978 |
| Goodwill & intangible assets | $3948 | $4018 | $4143 | |
| Total noncurrent assets | $5139 | $5221 | $5397 | |
| Total investments | ||||
| Total assets | $6626 | $6897 | $7123 | $7370 |
| Current liabilities | ||||
| Accounts payable | $297 | $287 | $279 | $305 |
| Deferred revenue | ||||
| Short long term debt | $362 | $343 | $322 | |
| Total current liabilities | $1542 | $1323 | $1330 | $1425 |
| Long term debt | $1795 | $1850 | $1747 | $1921 |
| Total noncurrent liabilities | $2510 | $2535 | $2651 | |
| Total debt | $2212 | $2210 | $2243 | |
| Total liabilities | $4135 | $3833 | $3865 | $4076 |
| Shareholders' equity | ||||
| Retained earnings | -$374 | $152 | $190 | $205 |
| Other shareholder equity | -$638 | -$677 | -$666 | -$636 |
| Total shareholder equity | $3064 | $3258 | $3293 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $334 | $365 | $339 | $438 |
| Short term investments | $33 | |||
| Net receivables | $695 | $685 | $747 | $673 |
| Inventory | $624 | $627 | $504 | $466 |
| Total current assets | $1973 | $1893 | $1837 | $1791 |
| Long term investments | ||||
| Property, plant & equipment | $978 | $961 | $966 | $967 |
| Goodwill & intangible assets | $4143 | $4591 | $6295 | $6490 |
| Total noncurrent assets | $5397 | $5750 | $7383 | $7551 |
| Total investments | ||||
| Total assets | $7370 | $7643 | $9220 | $9342 |
| Current liabilities | ||||
| Accounts payable | $305 | $279 | $268 | $305 |
| Deferred revenue | ||||
| Short long term debt | $322 | $118 | $182 | $299 |
| Total current liabilities | $1425 | $1170 | $1186 | $1317 |
| Long term debt | $1921 | $1826 | $2058 | $2108 |
| Total noncurrent liabilities | $2651 | $2661 | $2991 | $3055 |
| Total debt | $2243 | $2093 | $2240 | $2407 |
| Total liabilities | $4076 | $3832 | $4177 | $4372 |
| Shareholders' equity | ||||
| Retained earnings | $205 | $456 | $1560 | $1233 |
| Other shareholder equity | -$636 | -$628 | -$592 | -$464 |
| Total shareholder equity | $3293 | $3811 | $5042 | $4967 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $951 | $984 | $953 | $1012 |
| Cost of revenue | $473 | $447 | $490 | |
| Gross Profit | $495 | $511 | $506 | $522 |
| Operating activities | ||||
| Research & development | $41 | $42 | $43 | |
| Selling, general & administrative | $399 | $415 | $409 | |
| Total operating expenses | $428 | $461 | $464 | $449 |
| Operating income | $50 | $42 | $73 | |
| Income from continuing operations | ||||
| EBIT | $51 | $50 | $75 | |
| Income tax expense | $17 | $38 | $14 | -$15 |
| Interest expense | -$21 | $17 | $18 | $23 |
| Net income | ||||
| Net income | -$494 | -$4 | $18 | $67 |
| Income (for common shares) | -$4 | $18 | $67 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3965 | $3922 | $4251 | $3342 |
| Cost of revenue | $1879 | $1795 | $1890 | $1685 |
| Gross Profit | $2086 | $2127 | $2361 | $1657 |
| Operating activities | ||||
| Research & development | $184 | $174 | $171 | |
| Selling, general & administrative | $1613 | $1589 | $1551 | $1435 |
| Total operating expenses | $2171 | $3064 | $1739 | $1669 |
| Operating income | -$85 | -$937 | $622 | -$12 |
| Income from continuing operations | ||||
| EBIT | -$94 | -$995 | $614 | -$12 |
| Income tax expense | -$43 | -$105 | $138 | $23 |
| Interest expense | $81 | $60 | $55 | $48 |
| Net income | ||||
| Net income | -$132 | -$950 | $421 | -$83 |
| Income (for common shares) | -$132 | -$950 | $421 | -$83 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$4 | $18 | $67 | |
| Operating activities | ||||
| Depreciation | $86 | $86 | $85 | |
| Business acquisitions & disposals | $13 | |||
| Stock-based compensation | $12 | $11 | $13 | |
| Total cash flows from operations | $208 | $25 | $160 | |
| Investing activities | ||||
| Capital expenditures | -$52 | -$34 | -$33 | |
| Investments | $1 | -$9 | ||
| Total cash flows from investing | -$140 | -$50 | -$43 | -$20 |
| Financing activities | ||||
| Dividends paid | -$95 | -$33 | -$29 | -$30 |
| Sale and purchase of stock | -$150 | -$150 | ||
| Net borrowings | $17 | $20 | $55 | |
| Total cash flows from financing | -$264 | -$171 | -$14 | -$128 |
| Effect of exchange rate | -$8 | $1 | -$11 | $13 |
| Change in cash and equivalents | -$38 | -$12 | -$43 | $25 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$132 | -$950 | $421 | -$83 |
| Operating activities | ||||
| Depreciation | $343 | $328 | $346 | $334 |
| Business acquisitions & disposals | $13 | -$220 | -$1077 | |
| Stock-based compensation | $46 | $59 | $48 | $47 |
| Total cash flows from operations | $377 | $517 | $657 | $635 |
| Investing activities | ||||
| Capital expenditures | -$142 | -$149 | -$142 | -$86 |
| Investments | $39 | $13 | $2 | $57 |
| Total cash flows from investing | -$89 | -$138 | -$358 | -$1106 |
| Financing activities | ||||
| Dividends paid | -$116 | -$104 | -$92 | -$88 |
| Sale and purchase of stock | -$300 | -$144 | -$149 | -$129 |
| Net borrowings | $119 | -$60 | -$102 | $749 |
| Total cash flows from financing | -$307 | -$329 | -$379 | $490 |
| Effect of exchange rate | -$12 | -$24 | -$19 | $14 |
| Change in cash and equivalents | -$31 | $26 | -$99 | $33 |
News
Fundamentals
| Market cap | $2.39B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 198.80M |
| Revenue | $3.90B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$413.00M |
| Revenue Q/Q | 0.42% |
| Revenue Y/Y | -0.91% |
| P/E ratio | -5.78 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.61 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$2.08 |
|---|---|
| ROA | -5.90% |
| ROE | N/A |
| Debt/Equity | 1.24 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.25 |
| Quick ratio | 0.84 |